Scheduled for launch at next week’s SupplySide East show in Secaucus, New Jersey, the extract, called EFLA956, is said to reduce the severity and duration of the common cold and associated symptoms, including sore throat, stuffy nose, cough and mucus build-up.
A study published in Phytotherapy Research in 2001 showed that Pelargonium extracts could modulate the immune system. The study also notes that the extract has been used against infectious diseases of the respiratory tract – conditions that affect adults between two and four times a year, and children up to 10 times per year. The estimated total cost of respiratory infections is about $40 billion.
“Pelargonium root extract shortens the duration and reduces the severity of throat, nose and bronchial irritations and ensures fast recovery,” explained Laurent Leduc, VP of the Health Division and Marketing for Frutarom USA. “Its triple-action profile ensures best results in fighting cold symptoms and makes it an important addition to our immune-health line.”
The extract is said to act in three ways: As an antimicrobial, antiviral and as a mediator of the body’s own immune-defense mechanisms.
According to Frutarom, the ingredient is standardized on Umckalin, a constituent unique to Pelargonium sidoides. It can be formulated into syrups, softgels, OTC preparations and tablets, said the company, and comes as a powder.